Smart Inhalers Market By Product Type (Inhalers, Metered dose inhalers, Dry powder inhalers, Nebulizers), By Application (COPD and Asthma), By Distribution channel (Hospitals, Retail pharmacies and Online pharmacies) and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Smart Inhalers Market size was valued at USD 10.8 billion in 2021, growing at a CAGR of 19.2% during the forecast period 2022-28. Smart Inhalers Market type of advanced inhaler that is digitally connected to apps on a phone or tablet, allowing clinicians to better manage a patient's medical condition. Smart inhalers use Bluetooth technology to track inhaler usage, remind patients to take their prescription, and collect data to aid in care planning. Aside from respiratory disease treatment, the gadget also sends a smartphone notice when a patient reaches a high pollen or extremely polluted location, allowing the patient to select whether or not to enter the area. Smart inhalers include sensors that allow patients to automatically track how often they use their inhaler, eliminating the possibility of human error. Many countries' public health systems have been overburdened as a result of the COVID-19 crisis, highlighting the critical need for long-term investment in health systems. As the COVID-19 epidemic spreads, the healthcare industry's growth is projected to slow. The life sciences industry is booming thanks to rising demand for in vitro diagnostics products and increased research and development efforts around the world. However, sales in the medical technology and imaging industry are declining as a result of fewer procedures being performed and equipment procurement being delayed or postponed. In addition, after the pandemic, virtual consultations with healthcare specialists are likely to become the standard way of care delivery. Digital health will continue to grow in the coming years as telehealth transforms care delivery. Nowadays there are extensively available connected devices for asthma and COPD, particularly smart inhalers, which monitor and track drug use accurately. Smart inhalers are robust and accurate and respiratory inhalers currently available are inadequate for proper asthma and COPD care. Instead of simply offering incrementally better drugs, this scenario suggests that smart inhalers have new ways to deliver and enable patient self-management.

  Key Developments: In 2019, collaboration between Novartis and Qualcomm, acquisition of Inspiro Medical by Opko Health, and acquisition of Gecko Health by Teva Pharmaceuticals for manufacturing smart inhalers. In September 2017, Adherium has received approval from FDA for its new Symbicort inhaler monitoring device SmartTouch for the Symbicort aerosol inhaler from AstraZeneca. In February 2017, Propeller Health collaborated with Novartis to develop a custom add-on sensor for the Breezhaler inhaler. In 2019, world’s first smart inhaler was approved by FDA-Teva’s ProAir Digihaler.

Smart Inhalers Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Smart Inhaler Market Dynamics

The Global smart inhalers market is driven by growing prevalence of people suffering from asthma and copd and technological developments in the development of better smart inhalers devices and systems. Chronic respiratory diseases account for about 8.3% of the global chronic disease burden, contributing to more than 4 million deaths a year, according to figures from the WHO. COPD is believed to occur in over 210 million people worldwide, with about 300 million asthma patients expected. In addition, untapped consumer potential is expected to provide lucrative opportunities for market development in smart inhalers in emerging regions with more population and shortage of healthcare amenities, however higher costs associated with the production of smart inhalers for asthma and COPD are expected to hinder the growth of smart inhalers market due to its unaffordability in the developing countries.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Smart Inhalers Market Segmentation

By Product Type
  • Inhalers
  • Metered dose inhalers
  • Dry powder inhalers
  • Nebulizers
By Application
  • Asthma
  • COPD
Distribution channel
  • Hospitals
  • Retail pharmacies
  • Online pharmacies
North America
  • US
  • Canada
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Korea
  • Australia & New Zealand
  • Rest of APAC
South America
  • Brazil
  • Argentina
  • Columbia
  • Mexico
  • Rest of South America
Middle East and Africa
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Adherium
  • AstraZeneca
  • Cohero health
  • GlaxoSmithKline
  • Gecko Health Innovations
  • Inspiro medical
  • Propeller Health